IL HB5405 | 2023-2024 | 103rd General Assembly
Status
Completed Legislative Action
Spectrum: Partisan Bill (Democrat 17-0)
Status: Passed on August 9 2024 - 100% progression
Action: 2024-08-09 - Public Act . . . . . . . . . 103-0860
Text: Latest bill text (Chaptered) [HTML]
Spectrum: Partisan Bill (Democrat 17-0)
Status: Passed on August 9 2024 - 100% progression
Action: 2024-08-09 - Public Act . . . . . . . . . 103-0860
Text: Latest bill text (Chaptered) [HTML]
Summary
Amends the Department of Public Health Powers and Duties Law of the Civil Administrative Code of Illinois. Sets forth requirements for any State entity or hospital that receives funding from the National Institutes of Health to conduct clinical trials of drugs or medical devices. Provides that the Department of Public Health, in consultation with relevant research organizations, shall analyze and provide recommendations on: (i) the demographic groups and populations that are currently represented and underrepresented in clinical trials in the State, including representation of groups based on their geographic location; (ii) the barriers that prevent persons who are members of underrepresented demographic groups from participating in clinical trials in the State, including barriers related to transportation; and (iii) approaches for how clinical trials can successfully partner with others to provide outreach to underrepresented communities. Provides that the Department shall report to the General Assembly on the results of the study by July 1, 2025. Sets forth definitions of underrepresented community and underrepresented demographic group. Provides that the Department shall review guidance published by the United States Food and Drug Administration and use existing infrastructure to encourage participation in clinical trials of drugs and medical devices by persons who are members of underrepresented demographic groups. Authorizes the Department to apply for any grants related to the encouragement of underrepresented demographic groups related to the United Food and Drug Administration's guidance.
Title
DIVERSITY IN CLINICAL TRIALS
Sponsors
Roll Calls
2024-05-25 - House - Concurrence in House (Y: 105 N: 0 NV: 2 Abs: 0) [PASS]
2024-05-16 - Senate - Third Reading in Senate (Y: 57 N: 1 NV: 1 Abs: 0) [PASS]
2024-04-19 - House - Third Reading in House (Y: 100 N: 6 NV: 1 Abs: 1) [PASS]
2024-05-16 - Senate - Third Reading in Senate (Y: 57 N: 1 NV: 1 Abs: 0) [PASS]
2024-04-19 - House - Third Reading in House (Y: 100 N: 6 NV: 1 Abs: 1) [PASS]
History
| Date | Chamber | Action |
|---|---|---|
| 2024-08-09 | House | Public Act . . . . . . . . . 103-0860 |
| 2024-08-09 | House | Effective Date January 1, 2025 |
| 2024-08-09 | House | Governor Approved |
| 2024-06-21 | House | Sent to the Governor |
| 2024-05-26 | Senate | Added as Alternate Co-Sponsor Sen. Adriane Johnson |
| 2024-05-26 | Senate | Added as Alternate Co-Sponsor Sen. Doris Turner |
| 2024-05-25 | House | Added Co-Sponsor Rep. Sharon Chung |
| 2024-05-25 | House | Added Co-Sponsor Rep. Joyce Mason |
| 2024-05-25 | House | Passed Both Houses |
| 2024-05-25 | House | House Concurs |
| 2024-05-25 | House | Senate Committee Amendment No. 1 House Concurs 105-000-000 |
| 2024-05-24 | House | Added Chief Co-Sponsor Rep. Kimberly Du Buclet |
| 2024-05-24 | House | Added Chief Co-Sponsor Rep. Camille Y. Lilly |
| 2024-05-22 | House | Senate Committee Amendment No. 1 Motion to Concur Recommends Be Adopted Public Health Committee; 008-000-000 |
| 2024-05-21 | House | Senate Committee Amendment No. 1 Motion to Concur Rules Referred to Public Health Committee |
| 2024-05-20 | House | Senate Committee Amendment No. 1 Motion to Concur Referred to Rules Committee |
| 2024-05-20 | House | Senate Committee Amendment No. 1 Motion Filed Concur Rep. Marcus C. Evans, Jr. |
| 2024-05-20 | House | Removed Co-Sponsor Rep. La Shawn K. Ford |
| 2024-05-20 | House | Added Co-Sponsor Rep. La Shawn K. Ford |
| 2024-05-16 | House | Placed on Calendar Order of Concurrence Senate Amendment(s) 1 |
| 2024-05-16 | House | Arrived in House |
| 2024-05-16 | Senate | Third Reading - Passed; 057-001-000 |
| 2024-05-09 | Senate | Placed on Calendar Order of 3rd Reading |
| 2024-05-09 | Senate | Second Reading |
| 2024-05-08 | Senate | Added as Alternate Chief Co-Sponsor Sen. Mattie Hunter |
| 2024-05-08 | Senate | Placed on Calendar Order of 2nd Reading May 9, 2024 |
| 2024-05-08 | Senate | Do Pass as Amended Public Health; 008-000-000 |
| 2024-05-07 | Senate | Added as Alternate Co-Sponsor Sen. Mary Edly-Allen |
| 2024-05-07 | Senate | Senate Committee Amendment No. 1 Adopted |
| 2024-05-07 | Senate | Senate Committee Amendment No. 1 Assignments Refers to Public Health |
| 2024-05-07 | Senate | Senate Committee Amendment No. 1 Referred to Assignments |
| 2024-05-07 | Senate | Senate Committee Amendment No. 1 Filed with Secretary by Sen. Julie A. Morrison |
| 2024-04-30 | Senate | Rule 2-10 Committee Deadline Established As May 10, 2024 |
| 2024-04-30 | Senate | Assigned to Public Health |
| 2024-04-24 | Senate | Referred to Assignments |
| 2024-04-24 | Senate | First Reading |
| 2024-04-24 | Senate | Chief Senate Sponsor Sen. Julie A. Morrison |
| 2024-04-24 | Senate | Placed on Calendar Order of First Reading |
| 2024-04-24 | Senate | Arrive in Senate |
| 2024-04-19 | House | Added Co-Sponsor Rep. Cyril Nichols |
| 2024-04-19 | House | Third Reading - Short Debate - Passed 100-006-000 |
| 2024-04-19 | House | Placed on Calendar Order of 3rd Reading - Short Debate |
| 2024-04-19 | House | House Floor Amendment No. 1 Adopted |
| 2024-04-19 | House | Added Co-Sponsor Rep. Kevin John Olickal |
| 2024-04-19 | House | Added Co-Sponsor Rep. Anne Stava-Murray |
| 2024-04-17 | House | Held on Calendar Order of Second Reading - Short Debate |
| 2024-04-17 | House | Second Reading - Short Debate |
| 2024-04-16 | House | House Floor Amendment No. 1 Recommends Be Adopted Public Health Committee; 007-000-000 |
| 2024-04-15 | House | House Floor Amendment No. 1 Rules Refers to Public Health Committee |
| 2024-04-15 | House | Added Co-Sponsor Rep. Robert "Bob" Rita |
| 2024-04-12 | House | Added Chief Co-Sponsor Rep. Eva-Dina Delgado |
| 2024-04-10 | House | Removed Co-Sponsor Rep. Camille Y. Lilly |
| 2024-04-10 | House | Added Co-Sponsor Rep. Camille Y. Lilly |
| 2024-04-04 | House | House Floor Amendment No. 1 Referred to Rules Committee |
| 2024-04-04 | House | House Floor Amendment No. 1 Filed with Clerk by Rep. Marcus C. Evans, Jr. |
| 2024-04-04 | House | Placed on Calendar 2nd Reading - Short Debate |
| 2024-04-04 | House | Added Co-Sponsor Rep. Theresa Mah |
| 2024-04-04 | House | Added Co-Sponsor Rep. Yolonda Morris |
| 2024-04-04 | House | Do Pass / Short Debate Public Health Committee; 009-000-000 |
| 2024-03-05 | House | Assigned to Public Health Committee |
| 2024-02-09 | House | Referred to Rules Committee |
| 2024-02-09 | House | First Reading |
| 2024-02-09 | House | Filed with the Clerk by Rep. Marcus C. Evans, Jr. |
